The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Castleman disease spectrum.
 
Johnson Khor
No Relationships to Disclose
 
Sheila K. Pierson
No Relationships to Disclose
 
Victoria Powers
No Relationships to Disclose
 
Mark-Avery Tamakloe
No Relationships to Disclose
 
Alexander Gorzewski
No Relationships to Disclose
 
Katherine Floess
No Relationships to Disclose
 
Jasira Ziglar
No Relationships to Disclose
 
Eric Haljasmaa
No Relationships to Disclose
 
Yue Ren
No Relationships to Disclose
 
Corey Casper
Consulting or Advisory Role - Curevo Vaccine; GlaxoSmithKline; Janssen; Temptime; Viracta Therapeutics
Research Funding - Janssen (Inst)
Patents, Royalties, Other Intellectual Property - Publication royalties from UpToDate
Travel, Accommodations, Expenses - GlaxoSmithKline; Temptime
 
Mary Jo Lechowicz
Consulting or Advisory Role - Kyowa Hakko Kirin
Travel, Accommodations, Expenses - Kyowa Hakko Kirin
 
Thomas S. Uldrick
Research Funding - Roche (Inst)
Patents, Royalties, Other Intellectual Property - US Patent 10,001,483
Other Relationship - Celgene; Merck
 
Amy Chadburn
No Relationships to Disclose
 
Gordan Srkalovic
Speakers' Bureau - EUSA Pharma; Foundation Medicine; Johnson & Johnson; Takeda
 
Megan S. Lim
No Relationships to Disclose
 
Hongzhe Li
No Relationships to Disclose
 
Elaine S. Jaffe
Stock and Other Ownership Interests - Gilead Sciences; Merck; Teva
 
Frits Van Rhee
Consulting or Advisory Role - Adicet Bio; Castleman Disease Collaborative Network; EUSA Pharma; Karyopharm Therapeutics; Kite, a Gilead company; Sanofi; Takeda
 
David C. Fajgenbaum
Research Funding - EUSA Pharma; Janssen
Other Relationship - Pfizer